Findings from a phase 2 trial showed that once-weekly TransCon CNP plus TransCon hGH produced durable growth and proportionality benefits in children with achondroplasia.
New dietary guidelines stress whole foods and reduced processing, with expanded, age-specific guidance for infants, children, and adolescents.
Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.
ACIP recommends use of GSK’s pentavalent MenACWY-CRM/MenB-4C vaccine when MenACWY and MenB are indicated at the same visit.
New research shows COVID-19 vaccination before or during pregnancy significantly lowers the risk of severe maternal illness and reduces rates of preterm birth.
GLP-1 receptor agonist use was associated with a lower risk of asthma exacerbations in adolescents with overweight or obesity.
According to Fleischer, epicutaneous immunotherapy represents a “marathon, not a sprint,” with potential long-term benefits when started young.
Results from a large randomized trial found that a midpregnancy blood test paired with targeted interventions improved neonatal outcomes in low-risk pregnancies.
New data suggest climate-related heat exposure may influence early developmental trajectories, particularly among vulnerable children.
David Fleischer, MD, says phase 3 VITESSE results show the Viaskin peanut patch offers a safe, practical desensitization option for young children with peanut allergy.
Reactions from the pediatric health care community poured in following swift changes to the US childhood vaccine schedule by the CDC.
FDA approved caplacizumab for pediatric patients ≥12 years with acquired TTP, supported by retrospective data showing 80% remission.
A look back at the FDA submissions and regulatory decisions in the pediatric health care space from December 2025.
With the priority review, the Prescription Drug User Fee Act date is set for April 29, 2026, for potential approval in this younger indication.
Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18.
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
View our Q4 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.
Daniela Carvalho, MD, highlighted the role of pediatricians in guiding families through early hearing intervention and language development decisions.
The FDA approved narsoplimab-wuug as the first targeted treatment for transplant-associated thrombotic microangiopathy in adults and children.
Those with regular access to care who did not receive, or were late on 2- and 4-month recommended vaccines, were more likely to not have any MMR vaccine by 2 years of age.
Take a look back at the top 5 FDA approvals of 2025.
Check the top pediatric conferences of 2025.
These were the most-viewed articles on the Contemporary Pediatrics website published in 2025.
Check out the top 5 nutrition articles of 2025.
As we continue our Countdown to 2026, take a look back at our top video interviews and packages of 2025.
Check out the top 5 nutrition articles of 2025.
In this recap article, take a look back at some of our top stories in the infectious diseases space in 2025.
Check out the top 5 nutrition articles of 2025.
Check out the top 5 pharmacology articles of 2025.
Join us for a recap of some of our top dermatology Puzzler cases from 2025.
